Your browser doesn't support javascript.
loading
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis.
Mascarenhas, John; Kremyanskaya, Marina; Patriarca, Andrea; Palandri, Francesca; Devos, Timothy; Passamonti, Francesco; Rampal, Raajit K; Mead, Adam J; Hobbs, Gabriella; Scandura, Joseph M; Talpaz, Moshe; Granacher, Nikki; Somervaille, Tim C P; Hoffman, Ronald; Wondergem, Marielle J; Salama, Mohamed E; Colak, Gozde; Cui, Jike; Kiladjian, Jean-Jacques; Vannucchi, Alessandro M; Verstovsek, Srdan; Curto-García, Natalia; Harrison, Claire; Gupta, Vikas.
Afiliación
  • Mascarenhas J; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Kremyanskaya M; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Patriarca A; Hematology Unit, Department of Translational Medicine, University of Eastern Piedmont and AOU Maggiore della Carità, Novara, Italy.
  • Palandri F; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Institute of Hematology "Seràgnoli", Bologna, Italy.
  • Devos T; Department of Hematology, University Hospitals Leuven and Department of Microbiology and Immunology, Laboratory of Molecular Immunology (Rega Institute), KU Leuven, Leuven, Belgium.
  • Passamonti F; University of Insubria, Varese, Italy.
  • Rampal RK; Memorial Sloan-Kettering Cancer Center, New York, NY.
  • Mead AJ; NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
  • Hobbs G; Division of Hematology/Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Scandura JM; Weill Cornell Medicine, New York, NY.
  • Talpaz M; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.
  • Granacher N; ZNA Stuivenberg, Antwerpen, Belgium.
  • Somervaille TCP; The Christie NHS Foundation Trust & Cancer Research UK Manchester Institute, Manchester, United Kingdom.
  • Hoffman R; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Wondergem MJ; Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • Salama ME; Sonic Healthcare USA, Austin, TX.
  • Colak G; Constellation Pharmaceuticals Inc, a MorphoSys Company, Boston, MA.
  • Cui J; Constellation Pharmaceuticals Inc, a MorphoSys Company, Boston, MA.
  • Kiladjian JJ; Hôpital Saint-Louis, Université de Paris, Paris, France.
  • Vannucchi AM; Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy.
  • Verstovsek S; Leukemia Department, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Curto-García N; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Harrison C; Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Gupta V; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
J Clin Oncol ; 41(32): 4993-5004, 2023 Nov 10.
Article en En | MEDLINE | ID: mdl-36881782
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Mielofibrosis Primaria / Inhibidores de las Cinasas Janus Tipo de estudio: Prognostic_studies Límite: Aged / Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Mielofibrosis Primaria / Inhibidores de las Cinasas Janus Tipo de estudio: Prognostic_studies Límite: Aged / Humans Idioma: En Revista: J Clin Oncol Año: 2023 Tipo del documento: Article